Physician

Roozbeh Mohajer, MD

According to 2025 Medicare claims, Roozbeh Mohajer, MD (NPI: 1457538449) practices hematology/oncology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94301-2302. Mohajer is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Mohajer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 826 traditional Medicare patients, billed 115,967 HCPCS/CPT codes, and received $2,750,014 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,194 prescription claims across 201 beneficiaries totaling $3,140,901 in drug costs, led by Brukinsa (Zanubrutinib). 2023 DME data shows 12 claims. Open Payments data shows 14 records totaling $4,179. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $86,206 to $2,750,014. Similarly, Part D prescription costs have risen steadily, from $786,539 to $3,140,901. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2015 Medicare payment: $86,206 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $89,817 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $34,409 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $61,345 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,047,109 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,406,751 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,409,599 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,899,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,131,960 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,750,014 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153691,229$86,206
20163661,312$89,817
2017189415$34,409
2018204761$61,345
201943260,238$1,047,109
202049270,817$1,406,751
202158888,433$1,409,599
2022737148,849$2,899,792
2023793156,946$3,131,960
2024826115,967$2,750,014

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.1M2015 Drug cost: $786,539 (USD; Tot_Drug_Cst)2016 Drug cost: $1,406,393 (USD; Tot_Drug_Cst)2017 Drug cost: $601,535 (USD; Tot_Drug_Cst)2018 Drug cost: $359,671 (USD; Tot_Drug_Cst)2019 Drug cost: $277,121 (USD; Tot_Drug_Cst)2020 Drug cost: $1,156,162 (USD; Tot_Drug_Cst)2021 Drug cost: $1,838,092 (USD; Tot_Drug_Cst)2022 Drug cost: $3,056,096 (USD; Tot_Drug_Cst)2023 Drug cost: $2,762,695 (USD; Tot_Drug_Cst)2024 Drug cost: $3,140,901 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015123587$786,539
2016129846$1,406,393
201793335$601,535
201837225$359,671
201957259$277,121
202091561$1,156,162
2021112686$1,838,092
20221791,114$3,056,096
20231891,200$2,762,695
20242011,194$3,140,901

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$12K$24K2015 Medicare payment: $24,214 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $18,342 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,109 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $213 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R29$24,214
2016N/R28$18,342
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R59$2,109
2023N/R12$213
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more211764$170
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more359525$110
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less129182$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's290488$15
J3489Injection, zoledronic acid, 1 mg100514$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib401,200$409,247
TagrissoOsimertinib Mesylate20600$346,643
InlytaAxitinib13382$319,602
ErleadaApalutamide19570$309,924
CalquenceAcalabrutinib Maleate24720$292,947

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$2,872AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.1$1,307Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Roozbeh Mohajer, MD?

Tedicare shows public-source Medicare data for Roozbeh Mohajer, MD (NPI 1457538449), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roozbeh Mohajer, MD have ACO affiliation data?

Roozbeh Mohajer, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Roozbeh Mohajer, MD?

Roozbeh Mohajer, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Roozbeh Mohajer, MD have Open Payments data?

Roozbeh Mohajer, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.